Cervical cancer screening strategies in women 65 years and older in the human papillomavirus era: A systematic review and meta‐analysis of human papillomavirus–based testing and self‐sampling approaches

The evidence supports recalibrating cervical cancer screening beyond age 65 years using risk-informed HPV-based strategies. Targeted catch-up testing and well-designed self-sampling pathways may improve coverage and detection of clinically relevant disease in select older populations.